EXC
63
2
PSX
34
-6
INTC
43
-2
QCOM
69
-2
BMY
40
2
ABBV
42
2
JBHT
35
12
THC
65
-3
AZO
48
5
MU
47
-7
CCL
33
2
NAVI
52
2
COF
55
3
WY
50
2
EXPE
50
-12
CSCO
53
2
VLO
30
-6
MET
37
-3
LRCX
45
-7
PFG
45
2
EXC
63
2
PSX
34
-6
INTC
43
-2
QCOM
69
-2
BMY
40
2
ABBV
42
2
JBHT
35
12
THC
65
-3
AZO
48
5
MU
47
-7
CCL
33
2
NAVI
52
2
COF
55
3
WY
50
2
EXPE
50
-12
CSCO
53
2
VLO
30
-6
MET
37
-3
LRCX
45
-7
PFG
45
2
Financhill
Back

Viking Therapeutics 10K Form

Buy
51

VKTX
Viking Therapeutics

Last Price:
64.71
Seasonality Move:
17.96%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive VKTX News And Ratings

See the #1 stock for the next 7 days that we like better than VKTX

VKTX Financial Statistics

Sales & Book Value

Annual Sales: --
Cash Flow: $-17.64M
Price / Cash Flow: 0
Annual Sales: $3.48
Price / Book: 18.67

Profitability

EPS (TTM): -0.92000
Net Income (TTM): $-85.9M
Gross Margin: $0
Return on Equity: 0%
Return on Assets: 0%

Viking Therapeutics Earnings Forecast

Key Viking Therapeutics Financial Ratios

  • The Interest Expense is 0.00% of Operating Income.
  • Per Share Earnings over the last 11 years have been positive in 5 years.

Viking Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: VKTX
CUSIP: 92686J
Website: vikingtherapeutics.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

VKTX Technical Analysis vs Fundamental Analysis

Buy
51
Viking Therapeutics (VKTX) is a Buy

Is Viking Therapeutics a Buy or a Sell?